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Reporter geneEvaluation of the function ofmicroRNAs (miRNAs ormiRs) throughmiRNA expression profiles during
neuronal differentiationplays a critical rolenot only in identifyinguniquemiRNAs relevant to cellular
development but also in understanding regulatory functions of the cell-specific miRNAs in living
organisms. Here, we examined the microarray-based miRNA expression profiles of G2 cells (recently
developed human neural stem cells) and monitored the expression pattern of known neuron-
specific miR-9 and miR-124a during neuronal differentiation of G2 cells in vitro and in vivo. Of 500
miRNAs analyzed by microarray of G2 cells, the expression of 90 miRNAs was significantly increased
during doxycycline-dependent neuronal differentiation of G2 cells and about 60 miRNAs showed a
gradual enhancement of gene expression as neuronal differentiation progressed. Real-time PCR
showed that expression of endogenous mature miR-9 was continuously and gradually increased in
a pattern dependent on the period of neuronal differentiation of G2 cells while the increased expres-
sion of neuron-specific mature miR-124a was barely observed during neurogenesis. Our recently
developed miRNA reporter imaging vectors (CMV/Gluc/3PT_miR-9 and CMV/Gluc/3PT_miR-124a)
containing Gaussia luciferase, CMV promoter and three copies of complementary nucleotides of each
corresponding miRNA showed that luciferase activity from CMV/Gluc/3PT_miR-9 was gradually
decreased both in vitro and in vivo in G2 cells induced to differentiate into neurons. However,
in vitro and in vivo bioluminescence signals for CMV/Gluc/3PT_miR-124a were not significantly dif-
ferent between undifferentiated and differentiated G2 cells. Our results demonstrate that biogenesis
of neuron-specific miR-124a is not necessary for doxycycline-dependent neurogenesis of G2 cells.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The investigation of key regulatory molecules during the pro-
cess of neuronal development is important not only foridentifying the crucial factors involved in determining neuronal
fate specification at the molecular level, but also for elucidating
the key activators needed to induce neuronal differentiation.
Recently, microRNAs (miRNAs or miRs), which are non-coding
RNA molecules of approximately 25 nucleotides, have emerged
as critical gene regulators involved in the developmental process
[1,2]. The study of regulatory functions and the expression pro-
files of microRNAs relevant to neuronal differentiation is neces-
sary to understand the biological function of these microRNAs
in neuronal development and to develop therapeutic agents for
the repair of neurodegenerative disorders [3,4]. Previous
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nesis have revealed the expression profiles of miRNAs not only
in mouse and human embryonic carcinoma cells, which can be
differentiated into neurons by retinoic acid (RA), but also in
mouse and human embryonic stem cells, based on the use of a
powerful tool, miRNA microarray analysis [5–7]. Recent evidence
has indicated that the ability of neural stem cells to generate a
neuronal lineage is regulated by a complex network between
miRNAs and their target genes [8]. A variety of neuron-specific
miRNAs including let-7, miR-124a, miR-9, and miR-132 have
been shown to negatively regulate non-neuronal target genes
such as PTBP-1 or the neuronal repressor, REST (RE-1 silencing
transcription factor) [8–11]. Amid increasing interest in the
development of treatments for neuron-related disorders, human
neural stem cells offer therapeutic potential in terms of cell-
based therapies for the repair of a wide range of neurological
diseases in the field of human medicine. In this study, we used
G2 cells, human neural stem cells that are easily differentiated
into neurons, regulated through induction by tetracycline
[12,13]. Genetically engineered G2 cells with v-myc overproduc-
tion under the control of tetracycline are able to maintain their
self-renewal capacity. In contrast, withdrawal of tetracycline
causes G2 cells to accelerate to a neuronal lineage, as proven
in a previous study using measurement of the expression level
of b-tubulin III, which is known as a neuronal marker.
Previous studies, which have involved a variety of in silico and
in vitro experimental methods including bioinformatics as well as
cellular and molecular approaches, have been hampered but the
fact that the experimental environments did not accurately repre-
sent the biological phenomenon in vivo [14–16]. In vivo molecular
imaging using an animal model is required to provide distinctive
biological information for cells of interest. Here, we investigated
a host of miRNA expression profiles using an underlying bioinfor-
matics approach, and we evaluated the in vivo monitoring as well
as in vitro analysis of miRNAs identified during neuronal differen-
tiation of G2 cells. We examined the expression profiles of 500
human miRNAs expressed in G2 cells during neuronal differentia-
tion using miRNA microarray analysis, and selected 68 miRNAs
that showed a gradually increasing pattern of expression during
neuronal differentiation of G2 cells. Of the miRNAs with significant
increases in their expression levels during neuronal differentiation,
in vitro and in vivo expression levels of two well-known neuron-
specific miRNAs, miR-9 and miR-124a, were monitored during
neuronal differentiation of G2 cells.
2. Materials and methods
2.1. Microarray analysis
The synthesis of target miRNA probes and hybridization reac-
tion were conducted using an miRNA labeling reagent and
hybridization kit (Agilent Technology, USA). Each 100 ng of total
RNAs were dephosphorylated with 15 units of calf intestine alka-
line phosphatase (CIP), followed by RNA denaturation with 40%
DMSO and 10-min incubation at 100 C. The dephosphorylated
RNA was then ligated with pCp-Cy3 mononucleotide and purified
using MicroBioSpin 6 columns (Bio-rad, USA). Labeled samples
were then resuspended with Hi-RPM Hybridization buffer and
Gene Expression Blocking Reagent, followed by boiling for 5 min
at 100 C and incubating on ice for 5 min. The denatured labeled
probes were pipetted onto an assembled Agilent miRNA
Microarray (15 K) and hybridized for 20 h at 55 C with 20 rpm
rotation in an Agilent Hybridization oven (Agilent Technology,
USA). The hybridized microarrays were washed according to the
manufacturer’s washing protocol (Agilent Technology, USA).2.2. Data acquisition and analysis
The hybridized images were scanned using Agilent’s DNA
microarray scanner and quantified using feature extraction soft-
ware (Agilent Technology, Palo Alto, CA). All data normalization
and identification of genes with significant changes in expression
were performed using GeneSpringGX 7.3 (Agilent Technology,
USA). The averages of the normalized ratios were obtained by
dividing the average value of normalized signal channel intensity
by the average value of normalized control channel intensity.
Functional annotation of genes was performed according to the
Gene OntologyTM Consortium (http://www.geneontology.org/in-
dex.shtml) by GeneSpringGX 7.3.
2.3. Cell culture and transient transfection studies
HB2.G2 cells were generated from HB1.F3, which is an immor-
talized human neural stem cell line derived from human fetal
brain, and were cultured in DMEM medium containing 10% fetal
bovine serum, 10 U/ml penicillin, 10 lg/ml streptomycin and
2 lg/ml of doxycycline [12]. To induce in vitro neuronal differenti-
ation, G2 cells were cultured with DMEM medium without serum
containing 5 ng/ml of epidermal growth factor (EGF). G2 differen-
tiation medium was replaced with new EGF-containing differenti-
ation medium every 2 days. The purified recombinant plasmids
CMV/Gluc/3PT_miR-124a, CMV/Gluc/3PT_miR-9 and CMV/Fluc
were transfected into each cell with lipofectamine reagent
(Invitrogen, Grand Island, NY) diluted in OPTI-MEM medium
(Gibco, Grand Island, NY). All transient transfections were carried
out in triplicate.
2.4. qRT-PCR analysis
Total small RNA prepared from G2 cells at 0, 2, 4, and 6 days
after neuronal differentiation was extracted by nuclease-free water
using the mirVanaTM miRNA isolation kit (Ambion, Austin, TX). To
verify the copy numbers of mature miR-124a and miR-9 during
neuronal differentiation of G2 cells, qRT-PCR was carried out using
the mirVanaTM qRT-PCR primer set (Ambion, Austin, TX) and
mirVanaTM qRT-PCR miRNA detection kits (Ambion, Austin, TX).
The levels of mature miR-124a and miR-9 were examined by PCR
amplification conditions (95 C for 3 min and 95 C for 15 s, 60 C
for 30 s for up to 40 amplification cycles) with SYBR Premix Ex
TaqTM (2) (Takara, Japan). The U6 snRNA primer set (Ambion,
Austin, TX) was used as a housekeeping RNA control for normaliza-
tion of the data. All reactions were performed using the iCycler
(Bio-Rad, Hercules, CA) system.
2.5. In vitro bioluminescence assay
Firefly luciferase assays and Gaussia luciferase assays were per-
formed using luciferase assay kits (Applied Biosystems) or Gaussia
luciferase assays kits (Targetingsystems, Cajon, CA). G2 cells were
washed with phosphate-buffered saline (PBS) and lysed in lysis
solution. G2 cell homogenates were collected and then transferred
to a 96-well microplate. Bioluminescence intensity was calculated
using a microplate luminometer (TR717; Applied Biosystems) with
an integration time of 20 s.
2.6. Immunofluorescence analysis performed to verify the neuronal
differentiation pattern using a neuronal marker in G2 cells
G2 cells were fixed with 4% formaldehyde for 20 min and
washed 3 times for 10 min using PBS solution. Blocking and
permeabilization procedures were performed simultaneously; the
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was added to the cells for 60 min. At each differentiation time
point the prepared G2 cells were incubated with primary antibod-
ies to Oct4 (Chemicon, Millipore, Watford, UK), Tuj1 (Covance,
Princeton, NJ, USA), MAP2 (Sigma–Aldrich, St. Louis, MO, USA),
GFAP (Cell Signaling Technology, Inc., Danvers. MA. USA), and O4
(R&D Systems, Inc., Minneapolis, MN, USA) overnight at 4 C.
After several washing steps for 10 min each, cells were incubated
with Alexa Flour secondary antibody for 90 min. G2 cells were
placed on a sterile cover slip with an aqueous mounting solution
containing 40, 6-diamidino-2-phenylindole dihydrochloride (DAPI)
(Vector Laboratories, Inc, CA).
2.7. Preparation of PLLA scaffold
The fibrous poly (L-lactic acid) (PLLA) scaffold was kindly pro-
vided by S.J. Lee (Ewha Womans’ University, College of
Pharmacy). PLLA scaffolds were fabricated from poly L-lactic acid
microfibers spun using a wet spinning method. For preparation
of the G2 cell/PLLA scaffold complex, the sterilization step of
PLLA scaffolds was carried out using 70% isopropyl alcohol over-
night, and PLLA scaffolds were soaked with G2 culture medium
for 12 h.
2.8. In vivo bioluminescence images
All experimental animals were housed under specific pathogen-
free conditions and handled in accordance with the guidelines
issued by the Institutional Animal Care and Use Committee of
Catholic Kwandong University International St. Mary’s Hospital.
G2 cells co-transfected with CMV/Fluc and CMV/Gluc3
PT_miRNA were incubated with PLLA scaffold pre-wetted with
70% ethanol in G2 cell medium for 2 h. For in vivo neuronal induc-
tion, 1  107 G2 cells carrying each plasmid vector were harvested
in PBS and resuspended in G2 differentiation medium containing
EGF. G2/scaffold coplex was subcutaneously implanted into both
thighs of nude mice (male BALB/c, 8 weeks). To acquire biolumi-
nescence images, the mice were anesthetized with 2% isoflurane
flow in O2 gas at a flow rate of 1 L/min through the nose cone by
placing the mouse in the induction chamber. For acquisition of
the in vivo Gaussia luciferase image, 0.01 mg of coelenterazine
(10110-1, Biotium, Hayward, CA) was directly injected into the
PLLA scaffold/G2 cell complex site. 3 mg/0.1 ml/mouse of luciferase
substrate luciferin was intraperitoneally injected to acquire the
firefly luciferase image. The bioluminescence imaging for the
in vivo firefly luciferase signal was acquired approximately 6 h
after acquisition of the Gaussia luciferase image by consideration
of the decay time of a light signal with a half-life of Gaussia
luciferase/coelenterazine reaction. Animals were placed in an
IVIS-200 equipped with a CCD camera (Xenogen, California).
Bioluminescence images were obtained by integrating and collect-
ing light for 5 min.
2.9. Statistical analysis
Data are presented as the mean ± standard error of the mean
(SEM). The Student’s t-test was used to calculate P values.
3. Results
3.1. Neuronal differentiation of G2 cells
G2 cells are human neural stem cells that have been modified
by the addition of the v-myc oncogene through retroviral transduc-
tion for immortalization [12,13]. The schematic illustration sum-
marizes the neuronal differentiation pattern of G2 cells (Fig. 1A).Briefly, v-myc oncogene expression is controlled by the presence
of doxycycline (a tetracycline derivative). The G2 cell line is main-
tained on the condition of the presence of doxycycline, and can be
induced to change to a neuronal lineage by the removal of
doxycycline.
When G2 cells were induced into a neuronal lineage by the
removal of serum and doxycycline and the addition of epidermal
growth factor (EGF), an intensive neurite outgrowth pattern was
observed to form over a number of days (Fig. 1B). The synaptic
clefts of postsynaptic neuron-like cells were observed 4 days after
neuronal differentiation. Immunofluorescence results verified that
G2 cells were differentiated into a neuronal lineage since high
expression of neuronal markers (TuJ1 and MAP2) was observed
rather than glial markers (GFAP and O4) in confocal microscope
images (Fig. 1C). Also, we verified that the expression of Oct4 (a
marker for undifferentiated cells) in the cytoplasm of G2 cells
was clearly decreased at 6 days after induction of neuronal differ-
entiation by removal of doxycycline. These results indicate that the
induction of G2 cells into a neuronal lineage by the removal of
doxycycline was successful.
3.2. miRNA expression profile of G2 cells during neuronal
differentiation
To investigate the miRNA expression profile during the differen-
tiation of G2 cells into a neuronal lineage a 0.5-KmiRNAmicroarray
was hybridizedwith total RNA samples extracted from various time
points of neuronal differentiation of G2 cells. The expression levels
of 470 human miRNAs spotted onto each microarray grid was
examined for samples collected at 0, 2, 4, and 6 days after induction
of neuronal differentiation in G2 cells. On the basis of normalization
and selection of fold-changed genes using GeneSpringGX 7.3
(Agilent’s Human miRNA Microarray), time-series gene expression
analysis revealed that 90 of 470 miRNAs showed up-regulation
greater than 2-fold in at least one of the three time points examined
after neuronal differentiation of G2 cells, compared with the undif-
ferentiated state of G2 cells. In particular, let-7f, miR-29b, miR-374,
miR-29c, miR-9 and miR-148 showed the most dramatically
enhanced differences in gene expression after neuronal differentia-
tion of G2 cells (Table 1). In total, 68 of these 90 miRNAs exhibited
time-dependent alterations in their gene expression patterns that
reached maximum levels on day 6 (Fig. 2). Several miRNAs have
been reported to very specifically and gradually increase during
neurogenesis including let-7a, let-7b, miR-9, miR-9*, miR-125a,
miR-125b, miR-124a, miR-135a, miR-218, miR-20a, miR-128a and
miR-128b [6,7,17,18]. Similar to the findings of other reports, the
expression levels of let-7a, let-7b, miR-9, miR-9*, miR-125a and
miR-125b in our experiments were gradually increased during
the neuronal differentiation of G2 cells (Fig. 2 and Table 2).
Interestingly, several miRNAs including miR-124a, miR-135a,
miR-218, miR-20a, miR-128a and miR-128b, which were supposed
to be gradually increased during normal neurogenesis, showed
aberrant miRNA expression during neuronal differentiation of G2
cells (Table 1). None of these aberrantly expressed miRNAs exhib-
ited a significant difference in the level of miRNA expression after
neuronal differentiation of G2 cells.
3.3. Aberrant gene expression pattern of neuron-specific miR-124a
during neuronal differentiation of G2 cells
Among the miRNAs aberrantly expressed during neurogenesis
of G2 cells, miR-124a was selected to use for verification of its
expression using real-time PCR. In normal neurogenesis, miR-
124a gradually increases in expression during neurogenesis and
is highly neuron-specific [6,19–21]. Similarly to the results of the
microRNA microarray, real-time PCR measurement of miR-124a
Fig. 1. Characterization of neuronal differentiation in G2 human neural stem cells. (A) Schematic illustration of the tetracycline-dependent neuronal differentiation of the G2
cell line. The HB2.G2 cell line was infected with two different viral vector systems, CMV-regulated tetracycline regulatory gene and tetracycline responsive element-
dependent v-myc expression vector. In the presence of doxycycline, tTA and doxycycline complex binds to 7 tetO sequences within the tetracycline responsive element,
causing the v-myc oncogene to be expressed and thereby maintaining the self-renewal of the immortalized human neural stem cells, HB2.G2. In contrast, the neuronal
differentiation of the G2 cell line can be induced by the removal of doxycycline. (B) G2 cells maintained in DMEM containing 10% FBS with doxycycline (2 lg/ml) were
transferred into DMEM containing 5 ng/ml of epidermal growth factor (EGF) in serum-free conditions to induce neuronal differentiation. Neurite-like processes were
observed at 4 days after induction of neuronal differentiation in G2 cells. (C) G2 cells at 6 days after induction of the neuronal lineage showed an immunoreactive pattern to
Tuj1, MAP2, GFAP, and O4. While a high fluorescence signal using the Oct4 antibody was detected in undifferentiated G2 cells, only very weak non-specific signals of Oct4
were found in differentiated G2 cells due to reduced expression of this protein. Scale bar, 20 lm.
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differentiation of G2 cells while expression of miR-9, used as a pos-
itive control, was gradually increased over time during neuronal
differentiation of G2 cells (Fig. 3A). The miR-124a expression pat-
tern was also studied in P19 cells, which are embryonal teratocar-
cinoma cells that have been differentiated into a neuronal lineage
controlled by treatment with RA. Similar to results shown in other
reports for the miR-124a expression pattern during neurogenesis,
the miR-124a expression level was gradually increased duringthe progression of neuronal differentiation in RA-treated P19 cells
[7,19] (Supplementary Fig. 1).
VAMP3 (vesicle-associated membrane protein 3) is necessary
for the efficient fusion between a synaptic vesicle and the synaptic
membrane, and it is targeted and transcriptionally repressed by
miR-124a during neurogenesis [22]. To see the functional activity
of miR-124a during neurogenesis of G2 cells the expression of
VAMP3 was measured by RT-PCR. The mRNA expression level
obtained by RT-PCR demonstrated that VAMP3 was not
Table 1
MicroiRNAs expression profile during neurogenesis of G2 cells.
miRNAs UD 2 D 4 D 6D
Up-regulated miRNAs
hsa-miR-7 1 522.2198 523.2151 292.2855
hsa-miR-29b 1 42.74225 57.29627 76.20358
hsa-miR-374 1 24.42929 31.31131 36.88374
hsa-miR-758 1 16.15773 10.68004 14.79463
hsa-miR-29c 1 13.68596 19.7659 27.33652
hsa-miR-9 1 10.60056 15.83843 26.63348
hsa-miR-148b 1 11.35026 28.26905 34.95855
hsa-miR-122a 1 11.06301 9.126085 16.51886
hsa-miR-146a 1 5.189159 14.2444 19.7232
hsa-miR-26b 1 5.824441 9.62672 14.56
hsa-miR-368 1 7.75968 10.30087 13.91249
hsa-miR-9* 1 7.64367 9.416519 13.2464
hsa-miR-19b 1 8.104035 10.48603 11.11664
hsa-miR-335 1 1.62836 5.84318 10.4418
hsa-miR-379 1 6.495094 6.488897 10.1394
hsa-miR-212 1 7.64367 10.5313 10.1193
hsa-miR-572 1 14.03861 8.195663 8.542398
hsa-miR-98 1 3.673534 6.434218 8.894021
hsa-miR-134 1 5.612838 6.579067 7.340769
hsa-let-7f 1 2.871265 4.92591 6.24624
Aberrantly expressed miRNAs
has-miR-128a 1 2.27625 0.819059 1.129478
has-miR-128b 1 0.010958 1 0.878327
has-miR-135a 1 0.345547 0.76329 0.405171
has-miR-218 1 0.26019 1 1.19274
has-miR-124a 1 1 1 1
has-miR-20a 1 1.672148 0.497116 1.565041
Fig. 2. Microarray-based microRNA expression analysis during neurogenesis in G2
cells. Clustering analysis represented relative expression levels of miRNAs at the
neuronal differentiation stage in G2 cells. 68 miRNAs showing both a greater than
twofold increase in expression between differentiation time points and a gradual
increase expression pattern during progression of neuronal differentiation were
selected and classified into four differentiation time point groups. Of the 68
miRNAs, several miRNAs including the miR-335, miR-26 and let-7 families showed
distinct expression patterns at each stage of neuronal differentiation in G2 cells.
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indicating no significant gradual increase in miR-124a expression
during neurogenesis of G2 cells (Fig. 3B).
3.4. In vitro and in vivo imaging of miR-9 and miR-124a during
neuronal differentiation of G2 cells
To further verify a few neuron-specific miRNAs that are inde-
pendent and dependent on neurogenesis of G2 cells, miR-9 and
miR-124a were selected and their expression levels were assessed
in vitro and in vivo. To image the endogenous gradual increase in
expression of miR-9 and the lack of significant change in expres-
sion of miR-124a in vitro and in vivo during neuronal differentia-
tion of G2 cells, two previously reported bioluminescent reporter
gene vectors for imaging miRNA were selected [18,19]. Briefly, a
Gaussia luciferase (Gluc) reporter vector was first designed having
the following components (in order): a cytomegalovirus (CMV)
promoter, an open reading frame of Gluc, 3 copies of perfectly
complementary sequences of mature miR-9 (designated as CMV/
Gluc/3PT_miR-9) or mature miR124a (designated as CMV/Gluc/
3PT_miR-124a). When each bioluminescent miRNA reporter
imaging system is bound by its cognate miRNA, the Gluc activity
is repressed by the normal function of the miRNAs. To evaluate
miR-9 and miR-124a expression patterns in vitro during neuronal
differentiation of G2 cells, a firefly luciferase (Fluc) reporter gene
regulated by a CMV promoter (designated as CMV/Fluc) was
cotransfected with CMV/Gluc/3PT_miR-9 or CMV/Gluc/
3PT_miR-124a into G2 cells for normalization of the study.
Similar to results found with miRNA microarray and real-time
PCR, the in vitro bioluminescence analysis showed that the Gluc
activity of the CMV/Gluc/3PT_miR-9 transfected into G2 cells
had neuronal differentiation-dependent gradual repression due
to the gradual increase in expression of miR-9 during neurogenesis
of G2 cells (Fig. 3C). Meanwhile, the Gluc expression pattern of the
CMV/Gluc/3PT_miR-124a demonstrated a small increase rather
than a decrease during neuronal differentiation of G2 cells. Also,
the CMV/Gluc/3PT_miR-124a vector was verified in the P19 cell
system, which shows a gradual decrease in Gluc activity due to
the gradual increase in miR-124a during neurogenesis of P19 cells
[19]. Unlike G2 cells, P19 cells transfected with CMV/Gluc/
3PT_miR-124a vector displayed Gluc activity that continuously
decreased during neuronal differentiation of P19 cells, a finding
that is consistent with a gradual increase in miR-124a expression
during the progression of neuronal differentiation of these cells
(Supplementary Fig. 2).
For in vivo study, we used a PLLA scaffold, which can be utilized
as a microenvironmental space, to support cell growth as well as toTable 2
List of up-regulated miRNAs during neurogenesis.
Up-regulated miRNA list
during neurogenesis in P19
cells [7]
Abundant
expression in
adult brain [27]
Up-regulated miRNA list
during neurogenesis in
ESC [5]
Let-7a Let-7a Let-7b
Let-7b Let-7b Let-7d
miR-9 Let-7c Let-7g
miR-9* miR-9 miR-124a
miR-100 miR-9* miR-125a
miR-124a miR-128 miR-135a
miR-125a miR-132 miR-181
miR-125b miR-125a miR-22
miR-135a miR-125b miR-26
miR-16 miR-124a miR-9
miR-218 miR-9*
miR-30a
miR-98
Fig. 3. In vitro validation of miR-9 and miR-124a expression patterns in neuronal differentiation of G2 cells. (A) Small RNA was extracted from G2 cells at 0, 2, 4, and 6 days
after neuronal induction by the withdrawal of doxycycline. Quantitative RT-PCR analysis showed that the endogenous mature miR-9 expression level was gradually increased
following the induction of neuronal differentiation of G2 cells. In contrast, there was no significant change in the expression level of mature miR-124a during neurogenesis.
U6 snRNA was used as an internal control. Results are expressed as the mean (SD) of triplicate experiments. (B) qRT-PCR analysis was performed to assess the expression level
of an miR-124a target gene using specific primers for VAMP3, a putative target gene for miR-124a. Similar expression patterns of VAMP3 were detected at each neuronal
differentiation time point in G2 cells. (C) The constructed CMV/Gluc/3PT_miR-9 (or CMV/Gluc/3PT_miR-124a) plasmid vector was transiently transfected into
undifferentiated G2 cells, and Gaussia luciferase activity was measured at each neuronal differentiation time point in G2 cells. A gradual decrease in the level of Gaussia
luciferase was found in the treatment group of CMV/Gluc/3PT_miR-9, due to the increase in expression of miRNA-9 during neuronal differentiation of G2 cells. CMV/Gluc/
3PT_miR-124a-treated G2 cells showed similar activity levels of Gaussia luciferase until 2 days after neuronal differentiation. (*P < 0.05, **P < 0.01).
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in vivo imaging [23]. CMV/Gluc/miR-9_3PT or CMV/Gluc/
3PT_miR-124a was co-transfected into 1  107 G2 cells with
CMV/Fluc (an internal control for normalization), which supplied
constant Fluc activity regardless of the presence of miRNAs or
doxycycline, and the harvested G2 cells were incorporated into
pre-wetted PLLA scaffolds. G2 cell/scaffold complex containing
doxycycline in re-suspension buffer for maintenance of self-
renewal function in G2 cells was surgically implanted into the left
thigh of a mouse and G2 cell/scaffold complex without doxycycline
for induction of neuronal differentiation of G2 cells was implanted
into the right thigh of a mouse. Although transient transfection of
each CMV/Fluc, CMV/Gluc/miR-9_3PT, or CMV/Gluc/3PT_miR-
124a resulted in a luciferase signal that was reduced over time in
the in vivo experiments, faster gradual regression of Gluc intensity
from CMV/Gluc/miR-9_3PT was observed in the right thigh at
1 day after neuronal differentiation of G2 cells due to the gradual
increase in miR-9 expression during neurogenesis of G2 cells, com-
pared with that of the left thigh, which was not induced to progress
to in vivo neuronal differentiation (Fig. 4A). Meanwhile, the Gluc
activity of CMV/Gluc/3PT_miR-124a in both thighs of nude mice
was not significantly different between the undifferentiated and
differentiated G2 cell groups due to the fact that there was nosignificant increase in miR-124a during neuronal differentiation
of G2 cells (Fig. 4B). As expected, in vivo Fluc signals of CMV/Fluc
acquired by the IVIS 100 imaging device showed relatively similar
bioluminescence signal patterns between the left and right thighs
(Fig. 4A and B). The Gluc signal ratio between the undifferentiated
and differentiated groups, as determined by quantitative region of
interest (ROI) analysis, showed that the Gluc signal of CMV/Gluc/
3PT_miR-9 was dramatically and gradually reduced compared
to that of CMV/Gluc/3PT_miR-124a (Fig. 4C). An in vivo experi-
ment regarding the changes in miR-124a expression levels during
neurogenesis of P19 cells was also performed. CMV/Gluc/
3PT_miR-124a- and CMV/Fluc-cotransfected P19 cells were sub-
cutaneously implanted into both thighs of mice. When neuronal
differentiation of P19 cells by RA treatment was induced in the
right thigh of mice, a gradually decreased luciferase signal was
observed until 2 days after induction (Supplementary Fig. 3A).
The fold-change in the ratios calculated from the ROI analysis com-
pared between the undifferentiated and differentiated groups was
higher for the differences in Gluc repression found after neuronal
differentiation (Supplementary Fig. 3B). A similar cell survival pat-
tern between two cell implantation groups was found by measur-
ing the in vivo Fluc activity. To verify the neuronal differentiation
pattern of G2 cells in vivo, G2 cell/PLLA scaffold from both thighs
Fig. 4. In vivo monitoring of miR-9 (or miR-124a) expression levels during the progression of neuronal differentiation of G2 cells in nude mice. (A and B) CMV/Gluc/
3PT_miR-9 and CMV-Fluc (firefly luciferase vector regulated by CMV promoter) were co-transfected into undifferentiated G2 cells, and harvested G2 cells were incorporated
into a pre-wetted PLLA scaffold. To induce neuronal differentiation, G2 cells were resuspended with PBS buffer without doxycycline. As soon as the G2 cell/PLLA complex was
surgically implanted into the thighs of mice, the in vivo Gaussia luciferase signal was visualized and showed that a more strongly decreased signal was present in the group
with induced neuronal differentiation in the right thigh of the mice, compared to that in the undifferentiated group (left thigh). In contrast, CMV/Gluc/3PT_miR-124a-
transfected G2 cells inside the PLLA scaffold in nude mice showed similar Gaussia luciferase signals between undifferentiated and differentiated G2 cells until 2 days after
neuronal differentiation. Firefly luciferase signal was used to detect the survival of G2 cells for an in vivo normalization study. (C) Quantitative ROI data acquired from
bioluminescence image results showed a continuously decreasing pattern for the ratio value between undifferentiated (Undiff.) and differentiated (Diff.) groups in CMV/Gluc/
3PT_miR-9-transfected G2 cells at 3 days, compared to that of CMV/Gluc/3PT_miR-124a-transfected G2 cells (*P < 0.05, **P < 0.01).
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fixed with 4% formaldehyde solution. Immunofluorescence stain-
ing using antibodies to Oct4 (a stem cell marker) and Neuro-D (a
neuronal marker) showed that a high expression level of Oct4
was found in the cytoplasm of undifferentiated G2 cells isolated
from the left thigh, whereas the Oct4 expression level was
decreased after neuronal differentiation of G2 cells isolated from
the right thigh (Supplementary Fig. 4A). In addition, the Neuro-D
expression level was significantly increased in G2 cells isolated
from the right thigh compared to G2 cells isolated from the left
thigh (Supplementary Fig. 4B). These results indicated the success-
ful neuronal induction of G2 cells in vivo.
4. Discussion
Recently, a wide range of miRNAs controlling developmental
timing, such as the process of neuronal differentiation, have been
found in vertebrates as well as invertebrates [24–26]. The global
miRNA expression profiles found during neurogenesis have been
explored using a host of technological approaches, including
microarray analysis [7,27,28]. Representative neuronal-specific
miRNAs such as miR-124a and miR-9 identified by microarray
are gradually up-regulated during neuronal development by sup-
pressing a variety of nonneuronal genes. In this study, G2 cells,
which conditionally express the v-myc oncogene with tetracycline
for maintenance of their self-renewal ability, were utilized due to
the simple manipulation of G2 cells to generate a neuronal lineage.
Although the cellular characteristics of recently developed G2
human neural stem cells were reported during the process of neu-
ronal differentiation [13], the molecular characteristics of G2 cells,
including global mRNA and miRNA expression analysis, were not
well investigated. In our study, overall miRNA expression profiles
of G2 cells after removal of doxycycline showed a strong correla-
tion with the normal miRNA expression pattern of brain tissue.
Several known neuron-specific miRNAs including miR-9, miR-9*,
miR-132, miR-125a and miR-125b showed gradually increased
expression levels after neuronal differentiation of G2 cells.
Meanwhile, neuron-specific miRNAs including miR-124a, miR-
135a, miR-218, miR-20a, miR-128a and miR-128b had aberrant
miRNA expression profiles during neuronal differentiation of G2
cells, showing no significant increases in miRNA expression after
neuronal differentiation of G2 cells. Compared with other reported
neuronal progenitor cells, G2 cell showed aberrant expression of
these neuron-specific miRNAs, suggesting G2 cell is not efficient
as a model system for neuronal differentiation. The aberrant
miRNA expression might have resulted from the modification of
these cells by retroviral transduction of v-myc oncogene. Further
studies are required to verify this. In vitro and in vivo studies of
G2 cells using bioluminescent miRNA reporter imaging systems
verified the abnormal expression of miR-124a during neuronal dif-
ferentiation of G2 cells. Meanwhile, in vitro and in vivo studies of
P19 cells demonstrated that miR-124a expression was normally
and gradually increased during neurogenesis of P19 cells. These
data indicate that neurogenesis of G2 cells is independent of
miR-124a. These results imply that G2 cells during neurogenesis
have an miRNA expression pattern that is distinct from other cells
capable of differentiating into neuronal lineages, including P19
cells and NT2 cells (human teratocarcinoma cells). MiR-124a is
one of the essential and high expressed miRNAs during neuronal
differentiation. However, the miR-124a-independent neuronal dif-
ferentiation of G2 cells may demonstrates its altered cell nature in
gene expression by retroviral transduction of v-myc oncogene.
The advent of molecular imaging technology enables us to visu-
alize the gene expression pattern or implanted stem cells based on
a reporter gene system in vivo [29,30]. A recently developed miRNAimaging system using an optical reporter gene provides a powerful
tool for non-invasive monitoring of an miRNA expression levels in
cancer or neuronal differentiation [18,31,32]. In this study, the
in vivo miRNA imaging system successfully monitored the unique
miRNA expression patterns from neuronally differentiated G2 cells.
CMV/Fluc was cotransfected with CMV/Gluc/3PT_miR-9 or CMV/
Gluc/3PT_miR-124a as an internal control to normalize Gluc
activities. CMV/Fluc was designed to be controlled by only CMV
promoter to express constant Fluc activity irrespective of the pres-
ence or absence of miR-9, miR-124a, and other substrates.
Constant Fluc activity confirmed the stable localization of
implanted G2 cells with PLLA scaffold throughout the 2 days of
in vivo neuronal differentiation without cell death or damage of
transfected vectors. The constant Fluc signal further demonstrated
the decrease in Gluc signal of CMV/Gluc/3PT_miR-9 or similar
Gluc signal of CMV/Gluc/3PT_miR-124a between undifferenti-
ated and differentiated G2 cells was resulted only from the
endogenous miR-9 or miR-124a.
Bioinformatics approaches based on miRNA microarray analysis
providing miRNA information on a large scale can be proven
through the evidence of real experimental data and eventually be
translated into an in vivo monitoring system for clinical applica-
tion. Therefore, the integrated research strategy ranging from a
bioinformatics approach to a non-invasive in vivo study using an
animal model could help researchers to provide complementary
information of high quality and with better reliability relative to
neuronal development and contribute to the better understanding
of brain development and neuronal differentiation in the field of
stem cell biology.
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